Over the last 7 days, the Life Sciences industry has risen 9.9%, driven by gains from EirGenix of 17%. In the past year, the industry is down 13%.
Has the Taiwanese Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 02 Oct 2025 | NT$38.1b | NT$2.5b | -NT$870,437,000.00 | 20x | -43.7x | 15.5x |
Sat, 30 Aug 2025 | NT$34.9b | NT$2.5b | -NT$819,216,000.00 | 20.7x | -42.7x | 14.2x |
Mon, 28 Jul 2025 | NT$34.9b | NT$2.5b | -NT$600,003,000.00 | 21.9x | -58.1x | 14.2x |
Wed, 25 Jun 2025 | NT$33.7b | NT$2.5b | -NT$600,003,000.00 | 23.5x | -56.2x | 13.7x |
Fri, 23 May 2025 | NT$31.9b | NT$2.5b | -NT$604,301,000.00 | 23x | -52.9x | 13x |
Sun, 20 Apr 2025 | NT$31.6b | NT$2.5b | -NT$540,128,000.00 | 24.3x | -58.5x | 12.8x |
Tue, 18 Mar 2025 | NT$36.7b | NT$2.6b | -NT$849,328,000.00 | 29.3x | -43.2x | 14.3x |
Thu, 13 Feb 2025 | NT$37.0b | NT$2.6b | -NT$854,432,000.00 | 23.3x | -43.3x | 14.4x |
Sat, 11 Jan 2025 | NT$36.5b | NT$2.6b | -NT$854,432,000.00 | 23.1x | -42.7x | 14.2x |
Mon, 09 Dec 2024 | NT$40.7b | NT$2.6b | -NT$854,432,000.00 | 23.8x | -47.6x | 15.9x |
Wed, 06 Nov 2024 | NT$43.0b | NT$2.5b | -NT$712,402,000.00 | 24.3x | -60.4x | 17.1x |
Fri, 04 Oct 2024 | NT$41.9b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -50x | 18.4x |
Sun, 01 Sep 2024 | NT$41.6b | NT$2.3b | -NT$836,610,000.00 | 22.2x | -49.7x | 18.3x |
Tue, 30 Jul 2024 | NT$41.7b | NT$2.1b | -NT$797,765,000.00 | 32.4x | -52.2x | 19.5x |
Thu, 27 Jun 2024 | NT$42.0b | NT$2.1b | -NT$797,765,000.00 | 34.5x | -52.7x | 19.7x |
Sat, 25 May 2024 | NT$39.8b | NT$2.1b | -NT$797,765,000.00 | 32.1x | -49.8x | 18.6x |
Mon, 22 Apr 2024 | NT$38.2b | NT$2.1b | -NT$923,759,000.00 | 30x | -41.4x | 18.1x |
Wed, 20 Mar 2024 | NT$40.4b | NT$2.1b | -NT$611,433,000.00 | 32.1x | -66.1x | 19.6x |
Fri, 16 Feb 2024 | NT$43.3b | NT$2.1b | -NT$610,218,000.00 | 32.5x | -71x | 20.9x |
Sun, 14 Jan 2024 | NT$44.9b | NT$2.1b | -NT$610,218,000.00 | 33.3x | -73.6x | 21.6x |
Tue, 12 Dec 2023 | NT$48.7b | NT$2.1b | -NT$610,218,000.00 | 33.4x | -79.9x | 23.5x |
Thu, 09 Nov 2023 | NT$49.3b | NT$2.2b | -NT$497,769,000.00 | 32.3x | -99.1x | 22.2x |
Sat, 07 Oct 2023 | NT$48.3b | NT$2.2b | -NT$497,769,000.00 | 31.4x | -97.1x | 21.7x |
Mon, 04 Sep 2023 | NT$43.9b | NT$2.2b | -NT$497,769,000.00 | 31.8x | -88.2x | 19.7x |
Wed, 02 Aug 2023 | NT$48.4b | NT$2.5b | -NT$274,767,000.00 | 43x | -176.3x | 19.8x |
Fri, 30 Jun 2023 | NT$51.0b | NT$2.5b | -NT$274,767,000.00 | 43.2x | -185.7x | 20.8x |
Sun, 28 May 2023 | NT$50.0b | NT$2.5b | -NT$262,467,000.00 | 43.4x | -190.4x | 20.2x |
Tue, 25 Apr 2023 | NT$47.4b | NT$2.7b | -NT$29,761,000.00 | 23.6x | -1591.1x | 17.8x |
Thu, 23 Mar 2023 | NT$48.7b | NT$2.6b | -NT$28,959,000.00 | 24.1x | -1680.2x | 18.4x |
Sat, 18 Feb 2023 | NT$51.0b | NT$2.7b | NT$85.3m | 19.7x | 598x | 19.1x |
Mon, 16 Jan 2023 | NT$45.2b | NT$2.7b | NT$85.3m | 18.9x | 529.9x | 16.9x |
Wed, 14 Dec 2022 | NT$56.5b | NT$2.7b | NT$139.5m | 18.9x | 405.4x | 21.1x |
Fri, 11 Nov 2022 | NT$43.1b | NT$3.0b | NT$480.6m | 23.4x | 89.7x | 14.4x |
Sun, 09 Oct 2022 | NT$46.8b | NT$3.0b | NT$482.8m | 24.6x | 97x | 15.6x |
97x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | -0.85% | |
Healthcare | 1.66% | |
Life Sciences | 9.86% | |
Clinical Research and Equipment | 9.86% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6589 EirGenix | NT$73.70 | 17.2% +NT$3.3b | -16.6% | PS23.3x | |
7837 Creative Life Science | NT$116.50 | 5.9% +NT$145.4m | n/a | n/a | |
7607 DuoGenic StemCells | NT$16.05 | 3.9% +NT$18.3m | -40.6% | n/a | |
4133 Abnova (Taiwan) | NT$26.10 | 0.8% +NT$12.1m | -14.6% | PS4.4x | |
6661 Welgene BiotechLtd | NT$22.45 | 0.2% +NT$1.2m | -10.7% | PE227.6x |